Quarterly EPS earnings growth: Apyx Medical (APYX)
Apyx Medical (APYX) is scaling its therapeutic sector through partnerships with aesthetic centers by implementing Renuvion systems. The quarterly EPS growth trajectory on the GURU.Markets chart demonstrates financial momentum, where the current mark equals 16.90. The company generates revenue from supplying plasma devices to plastic surgeons, while regular sales of disposable tips provide a steady income stream, offsetting previous regulatory risks.
%20Year-over-year%20net%20earnings%20per%20share%20growth%20for%20the%20last%2012%20months&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_APYX_-_Apyx-Medical_-_Year-over-year-net-earnings-per-share-growth-for-the-last-12-months "Apyx Medical Corporation (APYX) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/14/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns for Apyx Medical
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- balance sheet net asset value indicators:
- debt and liquidity details:
- earnings and valuation multiples information:
APYX - Net Profit|Expected Profit Apyx Medical|APYX - Price to Earnings Ratio|Projected Price to Earnings apyxmedical.com|APYX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Bovie Medical|APYX - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Apyx Medical|APYX - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months apyxmedical.com|APYX - Earnings growth in current year|Earnings growth forecast for next year Apyx Medical
- sales revenue and business income indicators:
Summary company analysis:Apyx Medical Corp - APYX
The investment attractiveness of Apyx Medical (APYX) depends on its ability to scale equipment sales amid geopolitical risks and electronics supply chain disruptions. The current value of 16.90 reflects the percentage growth in earnings per share, which, through the history of quarterly EPS growth, allows for tracking yield dynamics between reports, signaling the real health of the business or the risk of capital stagnation.
Competitors of Apyx Medical (APYX)
DXCM: Quarterly EPS earnings growth|PEN - Year-over-year net earnings per share change for the last twelve months|NOVT (Novanta Corp) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Haemonetics Company (HAE)|Year-over-year net earnings per share growth for the last 12 months INSP (Inspire Medical Systems)|PRCT (procept-biorobotics.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months CONMED CNMD|PLSE - Year-over-year net earnings per share growth for the last 12 months|InMode Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Picard Group|SRDX: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SENS|NPCE (NeuroPace) - Quarterly EPS earnings growth|Tactile Systems Technology Inc. (TCMD) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth SNWV|Year-over-year net earnings per share growth for the last 12 months Outset Medical Corp OM|Quarterly EPS earnings growth ELMD (Electromed)|Quarterly EPS earnings growth lensar.com LNSR|RCEL - Year-over-year earnings per share growth for the last twelve months|PROF: Year-over-year earnings per share growth for the last twelve months|BDMD (bairdmed.com) - Year-over-year net earnings per share growth for the last 12 months|EDAP TMS - Year-over-year earnings per one share growth for the last 12 months|ICCM (IceCure Medical Ltd.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Pulmonx Corp. LUNG|Year-over-year earnings per share growth for the last twelve months TELA Bio, Inc. (TELA)|cytosorbents.com (CTSO) - Net earnings per share growth for the trailing year|Sensus Healthcare Corp - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Zynex Corp ZYXI|electroCore Medical - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Vicarious Surgical Inc. RBOT|inspira-technologies.com (IINN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ICU (SeaStar Medical Holding Corporation)|Year-over-year earnings per share growth for the last twelve months IRIDEX Corp|Year-over-year net earnings per share growth for the last 12 months Intelligent Bio (INBS)|Quarterly EPS earnings growth XAIR|PFSA - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months STRATA Skin Sciences, Inc. SSKN|GCTK: Year-over-year earnings per share growth for the last 12 months|NAOV: Year-over-year net earnings per share growth for the last 12 months|Venus Concept Corporation - Year-over-year earnings per share growth rate for the last twelve months|NUWE: Quarterly EPS earnings growth|aethlonmedical.com (AEMD) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Asensus Surgical Inc|Avinger Inc. - Year-over-year net earnings per share trend for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BSGM (Biosig Technologies)|CUTR - Earnings per share growth in annualized terms for the last twelve months|Know Labs, Inc. - Year-over-year net earnings per share growth for the last 12 months|NARI: Year-over-year earnings per share growth for the last 12 months|NVRO: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months RSLS (ReShape Lifesciences)|Silk Road Medical Inc. (SILK) - Year-over-year earnings per share growth for the last twelve months
